--- title: "Regulatory Inspection Readiness | QbD Group" description: "Mock inspections, readiness assessments, back-room support and remediation for FDA and EU/EEA inspections, towards permanent inspection readiness." url: https://qbdgroup.com/en/services/quality-assurance/regulatory-inspection-readiness type: "Page" language: en publisher: "QbD Group" citation: "QbD Group, \"Regulatory Inspection Readiness | QbD Group\", https://qbdgroup.com/en/services/quality-assurance/regulatory-inspection-readiness" --- Quality Assurance # Regulatory Inspection Readiness An inspection should be a normal business day We support GxP-regulated companies before, during and after inspections by the FDA and EU/EEA competent authorities: from mock inspections and readiness assessments to back-room support, inspection responses and remediation programs. The goal: a state of permanent inspection readiness, without ad-hoc actions. - 20+ years Track record as inspection readiness partner - Top 20 Pharma & MedTech Preferred supplier - FDA & EU/EEA Inspection experience, with local on-site support The essentials ## What is inspection readiness? Inspection readiness means your facility, quality systems, records, people and operations can demonstrate a state of control at any moment, not only when an inspection is announced. It covers the full inspection lifecycle: preparing sites and teams before the inspectors arrive, supporting them while the inspection takes place, and responding to and remediating any findings afterwards. Done well, it becomes a permanent state rather than a recurring, costly preparation effort. Our approach ## How we support you Our inspection readiness support is organized around three types of efforts, depending on where you stand. ### Immediate readiness efforts When You have received an inspection announcement. How we respond A rapid assessment to close out open events, review open non-conformances and CAPA records before they are presented to inspectors, war room support, a mock inspection and SME preparation. ### Remediation efforts When You have received a Form 483, a Warning Letter or a major/critical audit finding. How we respond A response and commitment strategy, a remediation plan, CAPA governance and development of the evidence that demonstrates your commitments have been met. ### Preventive efforts When Your quality system works well and you want to stay inspection-ready between inspections, or you face a CAPA backlog, adverse trends, an upcoming launch, weak audit results or high recurring inspection preparation costs. How we respond A baseline assessment, a roadmap, a mock inspection and a sustainable readiness program, with ongoing support such as periodic risk reviews, refresher mock inspections and staff preparation. > “Inspection readiness isn’t just about passing an inspection. It’s about building confidence in your quality systems, every day.” Common scenarios ## When we help ### Maintaining readiness between inspections Your quality system is in good shape and you want to keep it that way. We provide ongoing support between inspections: periodic risk reviews, refresher mock inspections, SME coaching and interview practice, and readiness checks after organizational or regulatory changes. Result Inspection readiness becomes part of daily operations, not a last-minute effort. Your quality system is in good shape and you want to keep it that way. We provide ongoing support between inspections: periodic risk reviews, refresher mock inspections, SME coaching and interview practice, and readiness checks after organizational or regulatory changes. Result Inspection readiness becomes part of daily operations, not a last-minute effort. Areas of expertise ## Our capabilities From a single gap assessment to a multi-site remediation program: - Mock inspections - Gap & readiness assessments - Front room & back room support - SME coaching & interview practice - Inspection team preparation - Inspection response & remediation - CAPA backlog recovery - Data integrity - Computerized system readiness - Validation & state of control - Sterile manufacturing & contamination control - Laboratory readiness - Supplier & CMO readiness - Readiness governance Proven results ## Reference cases Sterile pharma manufacturer ### Mock FDA inspection and remediation Challenge A sterile manufacturing and API site in Curaçao needed to prepare for an FDA inspection, with compliance, qualification and validation gaps to close. Approach Mock FDA inspection, quality system review and manufacturing assessment, followed by a remediation plan with CAPA coordination and execution: laboratory/QC improvements, validation execution and data integrity remediation. Front-room/back-room preparation, facility walkthroughs and batch/data trace exercises, with a team of up to 25 experts deployed on-site. Result The subsequent FDA inspection was completed successfully with no critical or major observations. Swiss CMO ### FDA readiness for a new product Challenge A pharmaceutical CMO with sterile manufacturing sites faced an FDA inspection linked to a new product, under both FDA and EU regulations. Approach An FDA inspection readiness program: mock FDA inspection, assessment of quality system, manufacturing, laboratory/QC and validation, data integrity review, pre-inspection documentation review, SME interview preparation, front-room/back-room preparation and batch/data trace exercises. Result The FDA inspection was completed successfully with no critical or major observations. Qualification and validation gaps were resolved before the inspectors arrived. Medical device CMO ### FDA inspection preparation and support Challenge A multi-site medical device CMO in the Netherlands, producing 3D-printed titanium prostheses, prepared for FDA and ANVISA inspections under FDA and ISO 13485 requirements. Approach Pre-inspection documentation review, on-site assessment, walkthroughs and batch/data trace exercises, a QMS update, and QMS and inspection training including front-room/back-room preparation, followed by support during the inspection and with the responses. Result Inspection completed successfully with no critical or major observations. Your partner ## Why QbD Group for inspection readiness? With a 20+ year track record as an inspection readiness partner, QbD Group is a preferred supplier for Top 20 Pharma and MedTech companies. ### Former FDA investigators Access to our network of former FDA investigators, who know how inspections are conducted from the inside. ### FDA and EU GMP expertise, local presence Deep expertise in FDA (21 CFR 210/211/820) and EU GMP requirements, including Annex 1 and Annex 11, with local on-site support in the US and Europe and remote delivery where it makes sense. ### Emergency Response Team Inspection announced or Warning Letter received? Our Emergency Response Team mobilizes experienced experts quickly. ### The latest FDA approach The FDA increasingly uses AI and data analytics to target and prepare inspections. We prepare you for how inspections are conducted today. ### End-to-end capabilities Mock inspections, readiness assessments and remediation, from a single site visit to a multi-workstream program. ### Permanent readiness with VLMcare [VLMcare](https://vlmcare.com) continuously monitors your validation status and flags drift, so you stay inspection-ready between inspections. [Partner with us](https://qbdgroup.com/en/contact) ## Let's talk Quality Assurance Whether you need QMS setup, audits, or ongoing compliance support, our QA experts are ready to help. Contact us --- Source: https://qbdgroup.com/en/services/quality-assurance/regulatory-inspection-readiness — © QbD Group. Quote freely with attribution and a link back.